Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Rang în acțiuni #25244
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Preț acțiune
$23.57
Ultima sincronizare: 2026-08-20
Capitalizare de piață
$51.76M
Schimbare (1 zi)
-0.08%
Schimbare (1 an)
289.59%
Țară
US
Tranzacționează Apollomics, Inc. (APLM)

Categorie

Prețul APLM cu capitalizarea de piață a B
Apollomics, Inc. Apollomics, Inc.
APLM
$23.57
Capitalizarea de piață a Apollomics, Inc.(APLM)
Capitalizare de piață: $51.76M
În anul August 2026, Apollomics, Inc. are o capitalizare de piață de $51.76M. Acest lucru face ca Apollomics, Inc. să fie a 25244th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Apollomics, Inc. din 2021 până în 2026
APLM în comparație cu top 5 cele mai populare stocks
Prețul pentru APLM Activul B Capitalizarea de piață a B Rezultate
Apollomics, Inc. Apollomics, Inc.
$2,393,755 $51.76M
$5.257T +10,155,837.95%
Apollomics, Inc. Apollomics, Inc.
$2,094,038 $51.76M
$4.599T +8,884,234.11%
Apollomics, Inc. Apollomics, Inc.
$1,869,970 $51.76M
$4.107T +7,933,585.06%
Apollomics, Inc. Apollomics, Inc.
$1,628,934 $51.76M
$3.577T +6,910,950.02%
Apollomics, Inc. Apollomics, Inc.
$1,278,332 $51.76M
$2.807T +5,423,454.20%